View in EDS

Effects of the Nonsteroidal MRA Finerenone With and Without Concomitant SGLT2 Inhibitor Use in Heart Failure.

Saved in:
Bibliographic Details
Title: Effects of the Nonsteroidal MRA Finerenone With and Without Concomitant SGLT2 Inhibitor Use in Heart Failure.
Authors: Vaduganathan M; Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.V., B.L.C., I.J.K., Z.M.M., A.S.D., S.D.S.)., Claggett BL; Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.V., B.L.C., I.J.K., Z.M.M., A.S.D., S.D.S.)., Kulac IJ; Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.V., B.L.C., I.J.K., Z.M.M., A.S.D., S.D.S.)., Miao ZM; Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.V., B.L.C., I.J.K., Z.M.M., A.S.D., S.D.S.)., Desai AS; Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.V., B.L.C., I.J.K., Z.M.M., A.S.D., S.D.S.)., Jhund PS; University of Glasgow, UK (P.S.J., A.D.H., J.J.V.M.)., Henderson AD; University of Glasgow, UK (P.S.J., A.D.H., J.J.V.M.)., Brinker M; Research & Development, Pharmaceuticals, Bayer, Berlin, Germany (M.B., J.L.-F., P.V., M.F.S., A.L.)., Lay-Flurrie J; Research & Development, Pharmaceuticals, Bayer, Berlin, Germany (M.B., J.L.-F., P.V., M.F.S., A.L.)., Viswanathan P; Research & Development, Pharmaceuticals, Bayer, Berlin, Germany (M.B., J.L.-F., P.V., M.F.S., A.L.)., Scheerer MF; Research & Development, Pharmaceuticals, Bayer, Berlin, Germany (M.B., J.L.-F., P.V., M.F.S., A.L.)., Lage A; Research & Development, Pharmaceuticals, Bayer, Berlin, Germany (M.B., J.L.-F., P.V., M.F.S., A.L.)., Lam CSP; National Heart Centre Singapore & Duke-National University of Singapore (C.S.P.L.)., Senni M; Papa Giovanni XXIII Hospital, University of Milano-Bicocca, Bergamo, Italy (M.S.)., Shah SJ; Northwestern University Feinberg School of Medicine, Chicago, IL (S.J.S.)., Voors AA; University of Groningen, Netherlands (A.A.V.)., Zannad F; University of Lorraine, Nancy, France (F.Z.)., Pitt B; University of Michigan, Ann Arbor (B.P.)., McMurray JJV; University of Glasgow, UK (P.S.J., A.D.H., J.J.V.M.)., Solomon SD; Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.V., B.L.C., I.J.K., Z.M.M., A.S.D., S.D.S.).
Source: Circulation [Circulation] 2025 Jan 14; Vol. 151 (2), pp. 149-158. Date of Electronic Publication: 2024 Sep 28.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4539 (Electronic) Linking ISSN: 00097322 NLM ISO Abbreviation: Circulation Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39340828
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Effects of the Nonsteroidal MRA Finerenone With and Without Concomitant SGLT2 Inhibitor Use in Heart Failure.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Vaduganathan+M%22">Vaduganathan M</searchLink>; Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.V., B.L.C., I.J.K., Z.M.M., A.S.D., S.D.S.).<br /><searchLink fieldCode="AU" term="%22Claggett+BL%22">Claggett BL</searchLink>; Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.V., B.L.C., I.J.K., Z.M.M., A.S.D., S.D.S.).<br /><searchLink fieldCode="AU" term="%22Kulac+IJ%22">Kulac IJ</searchLink>; Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.V., B.L.C., I.J.K., Z.M.M., A.S.D., S.D.S.).<br /><searchLink fieldCode="AU" term="%22Miao+ZM%22">Miao ZM</searchLink>; Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.V., B.L.C., I.J.K., Z.M.M., A.S.D., S.D.S.).<br /><searchLink fieldCode="AU" term="%22Desai+AS%22">Desai AS</searchLink>; Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.V., B.L.C., I.J.K., Z.M.M., A.S.D., S.D.S.).<br /><searchLink fieldCode="AU" term="%22Jhund+PS%22">Jhund PS</searchLink>; University of Glasgow, UK (P.S.J., A.D.H., J.J.V.M.).<br /><searchLink fieldCode="AU" term="%22Henderson+AD%22">Henderson AD</searchLink>; University of Glasgow, UK (P.S.J., A.D.H., J.J.V.M.).<br /><searchLink fieldCode="AU" term="%22Brinker+M%22">Brinker M</searchLink>; Research & Development, Pharmaceuticals, Bayer, Berlin, Germany (M.B., J.L.-F., P.V., M.F.S., A.L.).<br /><searchLink fieldCode="AU" term="%22Lay-Flurrie+J%22">Lay-Flurrie J</searchLink>; Research & Development, Pharmaceuticals, Bayer, Berlin, Germany (M.B., J.L.-F., P.V., M.F.S., A.L.).<br /><searchLink fieldCode="AU" term="%22Viswanathan+P%22">Viswanathan P</searchLink>; Research & Development, Pharmaceuticals, Bayer, Berlin, Germany (M.B., J.L.-F., P.V., M.F.S., A.L.).<br /><searchLink fieldCode="AU" term="%22Scheerer+MF%22">Scheerer MF</searchLink>; Research & Development, Pharmaceuticals, Bayer, Berlin, Germany (M.B., J.L.-F., P.V., M.F.S., A.L.).<br /><searchLink fieldCode="AU" term="%22Lage+A%22">Lage A</searchLink>; Research & Development, Pharmaceuticals, Bayer, Berlin, Germany (M.B., J.L.-F., P.V., M.F.S., A.L.).<br /><searchLink fieldCode="AU" term="%22Lam+CSP%22">Lam CSP</searchLink>; National Heart Centre Singapore & Duke-National University of Singapore (C.S.P.L.).<br /><searchLink fieldCode="AU" term="%22Senni+M%22">Senni M</searchLink>; Papa Giovanni XXIII Hospital, University of Milano-Bicocca, Bergamo, Italy (M.S.).<br /><searchLink fieldCode="AU" term="%22Shah+SJ%22">Shah SJ</searchLink>; Northwestern University Feinberg School of Medicine, Chicago, IL (S.J.S.).<br /><searchLink fieldCode="AU" term="%22Voors+AA%22">Voors AA</searchLink>; University of Groningen, Netherlands (A.A.V.).<br /><searchLink fieldCode="AU" term="%22Zannad+F%22">Zannad F</searchLink>; University of Lorraine, Nancy, France (F.Z.).<br /><searchLink fieldCode="AU" term="%22Pitt+B%22">Pitt B</searchLink>; University of Michigan, Ann Arbor (B.P.).<br /><searchLink fieldCode="AU" term="%22McMurray+JJV%22">McMurray JJV</searchLink>; University of Glasgow, UK (P.S.J., A.D.H., J.J.V.M.).<br /><searchLink fieldCode="AU" term="%22Solomon+SD%22">Solomon SD</searchLink>; Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.V., B.L.C., I.J.K., Z.M.M., A.S.D., S.D.S.).
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220147763%22">Circulation</searchLink> [Circulation] 2025 Jan 14; Vol. 151 (2), pp. 149-158. <i>Date of Electronic Publication: </i>2024 Sep 28.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0147763 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1524-4539 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200097322%22">00097322 </searchLink><i>NLM ISO Abbreviation: </i>Circulation <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39340828
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1161/CIRCULATIONAHA.124.072055
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 149
    Titles:
      – TitleFull: Effects of the Nonsteroidal MRA Finerenone With and Without Concomitant SGLT2 Inhibitor Use in Heart Failure.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Vaduganathan M
      – PersonEntity:
          Name:
            NameFull: Claggett BL
      – PersonEntity:
          Name:
            NameFull: Kulac IJ
      – PersonEntity:
          Name:
            NameFull: Miao ZM
      – PersonEntity:
          Name:
            NameFull: Desai AS
      – PersonEntity:
          Name:
            NameFull: Jhund PS
      – PersonEntity:
          Name:
            NameFull: Henderson AD
      – PersonEntity:
          Name:
            NameFull: Brinker M
      – PersonEntity:
          Name:
            NameFull: Lay-Flurrie J
      – PersonEntity:
          Name:
            NameFull: Viswanathan P
      – PersonEntity:
          Name:
            NameFull: Scheerer MF
      – PersonEntity:
          Name:
            NameFull: Lage A
      – PersonEntity:
          Name:
            NameFull: Lam CSP
      – PersonEntity:
          Name:
            NameFull: Senni M
      – PersonEntity:
          Name:
            NameFull: Shah SJ
      – PersonEntity:
          Name:
            NameFull: Voors AA
      – PersonEntity:
          Name:
            NameFull: Zannad F
      – PersonEntity:
          Name:
            NameFull: Pitt B
      – PersonEntity:
          Name:
            NameFull: McMurray JJV
      – PersonEntity:
          Name:
            NameFull: Solomon SD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 01
              Text: 2025 Jan 14
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1524-4539
          Numbering:
            – Type: volume
              Value: 151
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Circulation
              Type: main
ResultId 1